Suppr超能文献

人工尿失禁括约肌失败的模式和时机。

Patterns and timing of artificial urinary sphincter failure.

机构信息

Section of Urology, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC6038, Chicago, IL, 60637, USA.

Division of Urology, NorthShore University HealthSystem, Evanston, USA.

出版信息

World J Urol. 2018 Jun;36(6):939-945. doi: 10.1007/s00345-018-2203-0. Epub 2018 Jan 30.

Abstract

PURPOSE

To assess population-based trends in artificial urinary sphincter (AUS) placement after prostatectomy and determine the effect of timing on device survival and complications.

METHODS

We identified patients who underwent prostatectomy and AUS placement in SEER-Medicare from 2002 to 2011. We analyzed factors affecting the time of reoperation from AUS implantation and prostatectomy using multivariable Cox proportional hazard models.

RESULTS

In total, 841 men underwent AUS placement at a median 23 months after prostatectomy. Patients who underwent reoperation (28.5%) had higher clinical stage, more likely underwent open prostatectomy, or had prior sling placement (p < 0.03). There were no differences in rates of diabetes, smoking status, prior radiation therapy, or Charlson Comorbidity Index between those requiring reoperation vs. not (all p > 0.15). Patients with AUS placement > 15 months after prostatectomy (75%) initially experienced less need for operative reinterventions. Patients with later AUS placement were significantly more likely to have received radiation therapy [22.9 vs. 3.8% (p < 0.01)]. Nonetheless, late implantation was confirmed to be protective on multivariate analysis during the first 5 years after AUS placement [HR 0.79 (95% CI 0.67-0.92); p < 0.01]. Factors independently associated with a shorter interval time until reoperation included history of radiation [HR 1.93 (95% CI 1.33-2.80); p < 0.01] and history of prior sling [HR 1.70 (95% CI 1.08-2.68); p = 0.02]. Even for patients who underwent radiation therapy, delayed AUS implantation reduced reoperative risk.

CONCLUSIONS

Late AUS implantation in the Medicare population is associated with prolonged device survival initially, while radiation and prior sling surgery predict for earlier reoperation. Patients with delayed AUS implantation experience less immediate complications. Further work is required to identify patient-specific factors which may explain variability in timing for AUS.

摘要

目的

评估前列腺切除术后人工尿括约肌(AUS)植入的基于人群的趋势,并确定时机对设备存活率和并发症的影响。

方法

我们在 2002 年至 2011 年期间从 SEER-Medicare 中确定了接受前列腺切除术和 AUS 植入术的患者。我们使用多变量 Cox 比例风险模型分析了影响 AUS 植入和前列腺切除术之间再次手术时间的因素。

结果

共有 841 名男性在前列腺切除术后中位数为 23 个月时接受了 AUS 植入。需要再次手术的患者(28.5%)具有更高的临床分期,更可能接受开放性前列腺切除术,或有先前吊带放置史(p<0.03)。需要再次手术的患者与不需要再次手术的患者在糖尿病、吸烟状况、先前放疗或 Charlson 合并症指数方面无差异(均 p>0.15)。AUS 植入后>15 个月的患者(75%)最初经历较少的手术干预需求。较晚进行 AUS 植入的患者更有可能接受放疗[22.9%比 3.8%(p<0.01)]。然而,在 AUS 植入后的前 5 年,多变量分析证实延迟植入具有保护作用[HR 0.79(95%CI 0.67-0.92);p<0.01]。与再次手术间隔时间较短相关的独立因素包括放疗史[HR 1.93(95%CI 1.33-2.80);p<0.01]和先前吊带手术史[HR 1.70(95%CI 1.08-2.68);p=0.02]。即使对于接受放疗的患者,延迟 AUS 植入也降低了再次手术的风险。

结论

在 Medicare 人群中,晚期 AUS 植入与最初设备存活率延长相关,而放疗和先前吊带手术预测更早的再次手术。延迟 AUS 植入的患者经历较少的即时并发症。需要进一步研究以确定可能解释 AUS 时机差异的患者特定因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验